wazza
Bluelighter
- Joined
- Jun 24, 2001
- Messages
- 4,619
One very interesting link I found regarding this (and several other issues - mainly dealing with Shulgin and MDMA)
If MDMA is so wonderful, why hasn't it been marketed by any of the big drug companies? One reason is that the drug's commercial potential is small; another was that the US Food and Drug Administration (FDA) prohibited trials on humans. But perhaps the most significant obstacle to the commercial exploitation of MDMA is that it has already been patented - although the patent ran out years ago, a drug cannot be patented a second time. Before marketing a new drug, a drug company has to show that the safety risks are justified by the drug's benefits as a medicine, and this involves long and expensive trials. The only way of recouping that expense is by obtaining exclusive rights to sell the drug through holding its patent.
Anyone have any comments on this?
Full article at here